Serum thrombospondin‐2 level changes with liver stiffness improvement in patients with type 2 diabetes

Objective Baseline circulating thrombospondin‐2 (TSP2) level was identified as a potential novel hepatic fibrosis biomarker that associates with development and progression of hepatic fibrosis in patients with nonalcoholic fatty liver disease and type 2 diabetes. Here, we investigated whether circul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical endocrinology (Oxford) 2024-03, Vol.100 (3), p.230-237
Hauptverfasser:	Mak, Jimmy Ho Cheung, Lui, David Tak‐Wai, Fong, Carol Ho‐Yi, Cheung, Chloe Yu‐Yan, Wong, Ying, Lee, Alan Chun‐Hong, Hoo, Ruby Lai‐Chong, Xu, Aimin, Tan, Kathryn Choon‐Beng, Lam, Karen Siu‐Ling, Lee, Chi‐Ho
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Body weight Correlation analysis Diabetes Diabetes mellitus (non-insulin dependent) DPP4 inhibitor Fatty liver Fibrosis FIB‐4 Liver cirrhosis Liver diseases NFS Patients SGLT2 inhibitor Steatosis Thrombospondin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!